Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Number of holders
-
225
-
Total 13F shares, excl. options
-
292,444,452
-
Shares change
-
-362,784
-
Total reported value, excl. options
-
$3,570,548,028
-
Value change
-
+$6,804,421
-
Put/Call ratio
-
78%
-
Number of buys
-
123
-
Number of sells
-
-96
-
Price
-
$12.21
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q4 2022
278 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock as of Q4 2022.
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) has 225 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 292,444,452 shares
of 308,713,740 outstanding shares and own 95% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (27,642,917 shares), Avoro Capital Advisors LLC (26,800,000 shares), VANGUARD GROUP INC (26,538,371 shares), Redmile Group, LLC (20,249,789 shares), BlackRock Inc. (20,138,078 shares), MORGAN STANLEY (17,839,354 shares), JANUS HENDERSON GROUP PLC (13,694,549 shares), JPMORGAN CHASE & CO (13,547,368 shares), STATE STREET CORP (12,085,839 shares), and Palo Alto Investors LP (10,493,722 shares).
This table shows the top 225 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.